NEWS DETAIL

  • Source : Press Release
  • Date : 2021-04-06
  • Companies : Dascena, Inc.

Dascena Appoints Andrew Pucher as Chief Financial Officer

OAKLAND, Calif. – April 6, 2021 – Dascena, Inc., a machine learning algorithm company that
is targeting early disease intervention to improve patient care outcomes, today announced that
Andrew Pucher has been appointed as Chief Financial Officer. Mr. Pucher brings extensive
experience in capital markets, financing, and public company operations to Dascena.
“As Dascena continues to grow, the strength of our team is of the utmost importance. We are
thrilled to welcome Andrew to Dascena, whose combination of deep capital markets and
operating experience will be key to supporting the commercialization of our predictive algorithms
across multiple healthcare markets,” said Ritankar Das, Founder and Chief Executive Officer of
Dascena.

“I've been impressed with the progress that Dascena has made on the real-world application
and commercialization of its machine learning predictive algorithm platform,” said Mr. Pucher.
Our algorithms have the potential to significantly impact how patient care is managed, and
ultimately transform patient outcomes. I look forward to partnering with the team at Dascena to
deliver value to patients and our shareholders.”

Mr. Pucher joins Dascena from Tilray, Inc. where he served as Chief Corporate Development
Officer through the company's announced sale for $1.4 billion. Previously, Mr. Pucher was a
Managing Director at Goldman Sachs, where he served as a senior leader within the investment
bank's Global Healthcare Group in New York City, as well as the Canadian Investment Banking
franchise. Over the course of his career at Goldman Sachs, Mr. Pucher advised on more than
$200 billion in M&A and financing transactions across the healthcare sector. Mr. Pucher holds a
BBA from Simon Fraser University and JD/MBA from York University.

About Dascena
Dascena is developing machine learning diagnostic algorithms to enable early disease
intervention and improve care outcomes for patients. For more information, visit dascena.com.